Profound Medical Corp (PROF)
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
Masimo - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia
CervoMed Announces New Hire to Support Neflamapimod Development and Commercialization
DeepView® System highlighted at the annual British Burn Association conference
Evolus - Evolysse™ Recognized in 2025 Shape Skin Awards
BrainsWay Announces Gold Sponsorship at the 2025 Clinical TMS Society Annual Meeting in San Diego
Quantum-Si’s Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
Cytokinetics Announces Call For Proposals For Annual Corporate Giving Program
Transactions in Connection with Share Buy-back Program
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud